Ekachai Medical Care Public Company Limited (EKH.BK)
THB 6.25
(0.81%)
THB 6.25
(0.81%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 389.27 Million | 328.27 Million | 371.73 Million | 85.29 Million | 244.76 Million | 145.4 Million |
| Net Income | 297.26 Million | 685.74 Million | 424.75 Million | 79.59 Million | 206.61 Million | 143.72 Million |
| Depreciation & Amortization | 85.72 Million | 76.67 Million | 75.28 Million | 69.65 Million | 47.1 Million | 35.74 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 3.76 Million | 54.34 Million | -27 Million | -33.44 Million | 26.05 Million | -5.79 Million |
| Other non-cash items | 2.52 Million | -488.49 Million | -101.29 Million | -30.51 Million | -35.02 Million | -28.26 Million |
| Investing Cash Flow | -282.6 Million | 843.63 Thousand | -261.5 Million | 52.28 Million | -49.18 Million | -61.27 Million |
| Investments in PPE | -83.11 Million | -93.51 Million | -83.08 Million | -79.64 Million | -222.67 Million | -133.29 Million |
| Acquisitions | 134.44 Thousand | 571 Thousand | 703.93 Thousand | 552.56 Thousand | 1.65 Million | -4.57 Million |
| Investment purchases | -681.97 Million | -79 Million | -225 Million | -22.19 Million | -45.03 Million | - |
| Sales/Maturities of investments | 482.35 Million | 155.36 Million | 45.2 Million | 150.68 Million | 211.44 Million | 63.9 Million |
| Other Investing Activities | -174.13 Million | 17.42 Million | 673.71 Thousand | 2.89 Million | 5.42 Million | 8.11 Million |
| Financing Cash Flow | -114.68 Million | 269.51 Million | -100.64 Million | -166.79 Million | -74.77 Million | -78 Million |
| Debt repayment | -7.61 Million | -6.48 Million | -5.89 Million | -4.63 Million | - | - |
| Dividends payments | -215.96 Million | -77.99 Million | -137.47 Million | -126 Million | -99 Million | -72 Million |
| Common Stock Repurchased | - | -347.51 Million | -36.82 Million | -26.46 Million | - | - |
| Common Stock Issuance | 108.89 Million | 354 Million | 42.72 Million | - | - | - |
| Other Financing Activities | 108.89 Million | 347.51 Million | 36.82 Million | -9.68 Million | 24.22 Million | -6 Million |
| Accounts receivables | -4.93 Million | 18.73 Million | -59.84 Million | -4.81 Million | 13.15 Million | -17.04 Million |
| Accounts payables | 9.48 Million | 21.06 Million | 32.98 Million | -18.03 Million | 7.67 Million | 16.37 Million |
| Inventory | 4.73 Million | -6.04 Million | -5.19 Million | -3.92 Million | -7.68 Million | -4.52 Million |
| Other working capital | -5.52 Million | 20.59 Million | 5.04 Million | -6.66 Million | 12.91 Million | -1.27 Million |
| Cash at beginning of period | 776.09 Million | 177.46 Million | 167.87 Million | 197.08 Million | 76.29 Million | 70.16 Million |
| Cash at end of period | 768.08 Million | 776.09 Million | 177.46 Million | 167.87 Million | 197.08 Million | 76.29 Million |
| Capital Expenditure | -83.11 Million | -93.51 Million | -83.08 Million | -79.64 Million | -222.67 Million | -133.29 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -8.01 Million | 598.63 Million | 9.58 Million | -29.21 Million | 120.79 Million | 6.13 Million |
| Free Cash Flow | 306.15 Million | 234.75 Million | 288.65 Million | 5.64 Million | 22.08 Million | 12.11 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 62.31 Million | 55.64 Million | 99.66 Million | 297.26 Million | 115.92 Million | 32.81 Million |
| Depreciation & Amortization | 22.81 Million | 22.18 Million | 22.4 Million | 85.72 Million | 22.04 Million | 20.99 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 975 Thousand | -3.5 Million | 21.78 Million | 3.76 Million | -13.05 Million | 26.72 Million |
| Other non-cash items | 41.76 Million | 82.56 Million | -11.28 Million | 2.52 Million | -35.45 Million | 17.1 Million |
| Investing Cash Flow | 270.53 Million | 24.32 Million | 103.63 Million | -282.6 Million | -21.96 Million | -254.52 Million |
| Investments in PPE | -20.89 Million | -25.81 Million | -18.63 Million | -83.11 Million | -16.89 Million | -24.04 Million |
| Acquisitions | 40.47 Million | 40.11 Million | 32.44 Thousand | 134.44 Thousand | 8000.00 | 23 Thousand |
| Investment purchases | -409.65 Million | - | -356.11 Million | -681.97 Million | -15 Million | -240.7 Million |
| Sales/Maturities of investments | 660.61 Million | 10.02 Million | 478.35 Million | 482.35 Million | -8000.00 | -23 Thousand |
| Other Investing Activities | 265.9 Million | 13.09 Million | 126.25 Million | -174.13 Million | 9.93 Million | 10.21 Million |
| Financing Cash Flow | 70.87 Million | -41.35 Million | 61.18 Million | -114.68 Million | -1.92 Million | -172.09 Million |
| Debt repayment | -1.38 Million | -41.35 Million | -1.95 Million | -7.61 Million | -1.92 Million | -1.88 Million |
| Dividends payments | -212.72 Million | - | -220.00 | -215.96 Million | - | -215.96 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 284.98 Million | - | 63.13 Million | 108.89 Million | - | 45.75 Million |
| Other Financing Activities | 40 Million | 40 Million | 63.13 Million | 108.89 Million | - | 45.75 Million |
| Accounts receivables | -3.12 Million | 9.66 Million | 8.91 Million | -4.93 Million | -13.95 Million | 3.08 Million |
| Accounts payables | 2.43 Million | -17.11 Million | 15.12 Million | 9.48 Million | -242 Thousand | 21.19 Million |
| Inventory | 2.49 Million | 34 Thousand | -422.12 Thousand | 4.73 Million | -687 Thousand | 7.05 Million |
| Other working capital | -827 Thousand | 3.91 Million | -1.82 Million | -5.52 Million | 1.83 Million | -4.61 Million |
| Cash at beginning of period | 856.15 Million | 768.08 Million | 470.69 Million | 776.09 Million | 405.1 Million | 734.08 Million |
| Cash at end of period | 1.28 Billion | 856.15 Million | 768.08 Million | 768.08 Million | 470.69 Million | 405.1 Million |
| Capital Expenditure | -20.89 Million | -25.81 Million | -18.63 Million | -83.11 Million | -16.89 Million | -24.04 Million |
| Effect of forex changes on cash | - | - | -238.00 | - | - | - |
| Net cash flow / Change in cash | 425.44 Million | 88.07 Million | 297.38 Million | -8.01 Million | 65.59 Million | -328.98 Million |
| Free Cash Flow | 63.14 Million | 79.28 Million | 113.93 Million | 306.15 Million | 72.58 Million | 73.59 Million |
3611
PGM
AAREYDRUGS
PPPM
6724
JUBLPHARMA